BioSpace News Archive

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced a strategic multi-year agreement with Microsoft.

Castellum, Inc. (NYSE-American: CTM) announces its 2023 annual meeting of stockholders (“2023 Annual Meeting”) will be held on May 25, 2023, and that stockholders of record as of the close of business on March 31, 2023 will be entitled to notice of, and to vote at, the annual meeting and any adjournment or postponement thereof.

Asensus Surgical, Inc. today announced that it has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System.

EyePoint Pharmaceuticals, Inc. today announced multiple scientific presentations at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, being held April 23 – 27 in New Orleans, Louisiana.

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases.

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of its latest generation of ARTAS iX, which is now broadly available to physicians specializing in hair transplantation worldwide.

Societal CDMO, Inc. announced that the United States Food and Drug Administration has approved the company as a manufacturer of a commercial tablet product.

Nanoscope Therapeutics Inc. today announced the appointment of Vicente Anido Jr. , Ph.D., as a Strategic Advisor to the Company’s Board and Management.

ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Vitargus® Phase II Site Initiation Visit (SIV) at Srinagarind Hospital, Khon Kaen University (TH002) was successfully conducted on March 9-10, 2023.

DolCas Biotech, LLC and its concentrated turmeric extract, Curcugen®, have been selected by nutritional supplement company, Clear Within, for its vegan nutricosmetic.